NCT01510132View on ClinicalTrials.gov

Travacom Post Marketing Surveillance Study

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

January 31, 2012

Primary Completion Date

January 31, 2012

Study Completion Date

January 31, 2012

Conditions
Open-angle GlaucomaOcular Hypertension
Interventions
DRUG

Travoprost/timolol fixed combination (Travacom)

Commercially-marketed drug for the treatment of open-angle glaucoma or ocular hypertension

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY